Induction of Cross-protective Antibodies for Serogroup 33 by Pneumococcal Conjugate Vaccines

Clinical trial NCT07135453 · RECRUITING

Trial details

NCT number: NCT07135453
Sponsor: University of Alabama at Birmingham
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Vaccine Pneumococcal Disease

Start date: 2026-07-01
Primary completion: 2027-03-01
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.